Lucjusz Zaprutko

Prof. Lucjusz Zaprutko

Poznan University of Medical Sciences, Department of Organic Chemistry, Poznań, Poland
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DHDmytro Havrylyuk
Dmytro Havrylyuk
BZBorys Zimenkovsky
Borys Zimenkovsky
OVOlexandr Vasylenko
Olexandr Vasylenko
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko
AGAndrzej Gzella
Andrzej Gzella
Roman LesykRoman Lesyk
Roman Lesyk

1 May 2007 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Roman LesykRoman Lesyk
Roman Lesyk
OVOlena Vladzimirska
Olena Vladzimirska
Serhii HolotaSerhii Holota
Serhii Holota
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko
AGAndrzej Gzella
Andrzej Gzella

29 May 2018 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
DODorota Olender
Dorota Olender
JŻJustyna Żwawiak
Justyna Żwawiak
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko
The current concept in searching for new bioactive products, including mainly original active substances with potential application in pharmacy and medicine, is based on compounds with a previously determined structure, well-known properties, and biological activity profile. Nowadays, many commonly used drugs originated from natural sources. Moreover, some natural materials have become the source of leading structures for processing further chemical modifications. Many organic compounds with great therapeutic significance have the nitro group in their structure. Very often, nitro compounds are active substances in many well-known preparations belonging to different groups of medicines that are classified according to their pharmacological potencies. Moreover, the nitro group is part of the chemical structure of veterinary drugs. In this review, we describe many bioactive substances with the nitro group, divided into ten categories, including substances with exciting activity and that are currently undergoing clinical trials.

Verified
Journal Article
Open access
PDF file
Anna PawełczykAnna Pawełczyk
Anna Pawełczyk
KSKatarzyna Sowa-Kasprzak
Katarzyna Sowa-Kasprzak
DODorota Olender
Dorota Olender
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko
The design and discovery of novel drug candidates are the initial and most probably the crucial steps in the drug development process. One of the tasks of medicinal chemistry is to produce new molecules that have a desired biological effect. However, even today the search for new pharmaceuticals is a very complicated process that is hard to rationalize. Literature provides many scientific reports on future prospects of design of potentially useful drugs. Many trends have been proposed for the design of new drugs containing different structures (dimers, heterodimers, heteromers, adducts, associates, complexes, biooligomers, dendrimers, dual-, bivalent-, multifunction drugs and codrugs, identical or non-identical twin drugs, mixed or combo drugs, supramolecular particles and various nanoindividuals. Recently much attention has been paid to different strategies of molecular hybridization. In this paper, various molecular combinations were described e.g., drug–drug or drug-non-drug combinations which are expressed in a schematic multi-factor form called a molecular matrix, consisting of four factors: association mode, connection method, and the number of elements and linkers. One of the most popular trends is to create small–small molecule combinations such as different hybrids, codrugs, drug–drug conjugates (DDCs) and small-large molecule combinations such as antibody-drug conjugates (ADCs), polymer-drug conjugates (PDCs) or different prodrugs and macromolecular therapeutics. A review of the structural possibilities of active framework combinations indicates that a wide range of potentially effective novel-type compounds can be formed. What is particularly important is that new therapeutics can be obtained in fast, efficient, and selective methods using current trends in chemical synthesis and the design of drugs such as the “Lego” concept or rational green approach.

1 February 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DODorota Olender
Dorota Olender
JŻJustyna Żwawiak
Justyna Żwawiak
VLVictor Lukianchuk
Victor Lukianchuk
Roman LesykRoman Lesyk
Roman Lesyk
AKAleksandra Kropacz
Aleksandra Kropacz
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko

11 April 2014 in Phytochemistry Reviews
Verified
Journal Article
Open access
PDF file
Barbara Bednarczyk-CwynarBarbara Bednarczyk-Cwynar
Barbara Bednarczyk-Cwynar
Lucjusz ZaprutkoLucjusz Zaprutko
Lucjusz Zaprutko
During the last few decades more and more attention has been paid to triterpenes—a group of compounds with five- or four-ring skeleton and carboxyl, hydroxyl or oxo groups. Triterpenes with unsubstituted C-3 hydroxyl group can be easily transformed into appropriate ketones and then into oximes. The carbonyl group can be created not only from the hydroxyl group at C-3 position, but also at C-2, C-12 or C-28 positions. Several methods of creation of two = NOH groups within one molecule of triterpene are known. There are also known triterpenes with two carbonyl groups, e.g. at C-3 and C-11 positions, which differ in reactivity: among them only C-3 group can be transformed into oxime. A reactive hydroxyimine group can undergo the action of acylating agents, such as carboxylic acids or their derivatives, also the ones with significant pharmacological activity. Acyl derivatives of triterpenic oximes exhibit important pharmacological activity. The biological tests performed with the use of cell cultures inoculated with viruses showed inhibitory activity of some triterpenic acyloximes against type 1 HSV (H7N1), ECHO-6 and HIV-1 viruses. Another acylated oximes derived from triterpenes shown cytotoxic or antiproliferative activity against many lines of cancer cells. In many cases the pharmacological effects of the tested acyloxyiminotriterpenes were comparable to those of appropriate standard drugs. One of the newest application of acyl derivatives of triterpenic oximes is their ability to form organogels.